NCT05524597

Brief Summary

UCLA researchers looking for healthy older adults (aged 65+) to participate in a study investigating how writing about experiences can affect your brain and body. Once a week for 6 weeks, participants will write about their experiences and fill out online questionnaires. Participants will also come to the UCLA campus to complete a neuroimaging session (fMRI), provide a blood spot sample, and fill out questionnaires 2 times: once prior to the 6-week writing period and once immediately after the 6-week writing period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_1

Timeline
1mo left

Started Mar 2023

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Mar 2023Jun 2026

First Submitted

Initial submission to the registry

August 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 1, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

March 13, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 20, 2026

Status Verified

July 1, 2025

Enrollment Period

3.2 years

First QC Date

August 24, 2022

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (9)

  • Change in Psychological Distress

    Composite measure of depression, anxiety, stress (Beck Depression Inventory, Spielberger Trait Anxiety, and Perceived Stress Scale)

    Baseline, 6 weeks, 10 weeks

  • Change in Social Support

    measure of perceived social support (Social Provisions Scale)

    Baseline, 6 weeks, 10 weeks

  • Change in Social Participation

    measure of participation in social activities (Lifestyle Activities Questionnaire)

    Baseline, 6 weeks, 10 weeks

  • Change in Inflammatory Gene Expression

    changes in proinflammatory gene expression

    Baseline, 6 weeks, 10 weeks

  • Change in Dorsal Anterior Cingulate Cortex (dACC) Activity in response to stress

    Parameter estimates from dACC region-of-interest

    Baseline, 6 weeks

  • Change in Anterior Insula Activity in response to stress

    Parameter estimates from bilateral anterior insula region-of-interest

    Baseline, 6 weeks

  • Change in Amygdala Activity in response to threat

    Parameter estimates from bilateral amygdala region-of-interest

    Baseline, 6 weeks

  • Change in Ventral Striatum Activity in response to prosocial behavior

    Parameter estimates from bilateral ventral striatum region-of-interest

    Baseline, 6 weeks

  • Change in Septal Area Activity in response to prosocial behavior

    Parameter estimates from septal area region-of-interest

    Baseline, 6 weeks

Secondary Outcomes (2)

  • Change in Memory

    Baseline, 6 weeks, 10 weeks

  • Change in Beliefs about Aging

    Baseline, 6 weeks, 10 weeks

Study Arms (2)

Writing about Experiences

EXPERIMENTAL

Participants will be asked to write about experiences with familiar individuals in their lives.

Behavioral: Writing Intervention

Writing about Places

PLACEBO COMPARATOR

Participants will be asked to write about experiences with familiar places in their lives.

Behavioral: Writing Intervention

Interventions

Participants will be asked to write about different kinds of experiences.

Writing about ExperiencesWriting about Places

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Healthy adults age 65 years and older

You may not qualify if:

  • current smokers
  • active, uncontrolled medical disorders
  • chronic infection (e.g., Hepatitis C, HIV)
  • use of certain medications (steroid use, opioid use)
  • psychiatric disorders (e.g., current major depression, bipolar disorder)
  • body mass index (BMI) greater than 35
  • left-handed
  • claustrophobic
  • metal in body

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Cognitive Neuroscience

Los Angeles, California, 90095, United States

RECRUITING

Central Study Contacts

Naomi Eisenberger, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychology

Study Record Dates

First Submitted

August 24, 2022

First Posted

September 1, 2022

Study Start

March 13, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 20, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations